Opinion|Videos|July 26, 2024
Assessing Tear Film Abnormalities
Author(s)Alice Epitropoulos, MD, Laura M. Periman, MD
Dry eye experts discuss tear film assessment techniques and emphasize the importance of distinguishing between aqueous-deficient and evaporative dry eye for targeted treatment approaches.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- How do you assess for tear film abnormalities? What do the results of these tests tell us about the root cause of dry eye?
- Why is it important to differentiate aqueous-deficient from evaporative dry eye?
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
Dry eye cases rise with heavy screen use and younger patients; learn modern workups spotlighting MGD, etiology-driven treatments, and collaborative care reshaping outcomes.
Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.
Optometrist–ophthalmologist co-management targets dry eye early, improves cataract and refractive surgery satisfaction, and uses advanced diagnostics and treatments for healthier ocular surfaces.
Their conversation covers a holistic, cross-specialty approach to ocular surface disease and the unmet need driving a new model of dry eye care in Ireland.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP
3
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
4
Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery
5